Huan Gui

Guiyang Medical University — China

Computer Science · Physical Sciences

24h-index2.3kcitations67works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Topic Modeling(8), Cancer Immunotherapy and Biomarkers(7), Immunotherapy and Immune Responses(7), Complex Network Analysis Techniques(6), Immune Cell Function and Interaction(6)

Publications67 total

Effect of human serum albumin on clinical outcomes in pediatric patients undergoing gastrointestinal surgery
Frontiers in Pediatrics·2025Open Access
ReMem: Mutual Information-Aware Fine-tuning of Pretrained Vision Transformers for Effective Knowledge Distillation
arXiv (Cornell University)·2025Open Access
Anti-TNFR2 antibody and HMGN1 combined with TIL cell therapy inhibits colorectal cancer progression by enhancing immune response
Biochemical and Biophysical Research Communications·2025· 1 cited
Polyamine Metabolism Promotes the Progression of Thyroid Carcinoma by Regulating the Immune Phenotype of Tumor Associated Macrophages
Smart Medicine·2025· 3 citedOpen Access
Anti-TNFR2 Antibody and HMGN1 Combined with TIL Cell Therapy Inhibits Colorectal Cancer Progression by Enhancing Immune Response
2025Open Access
Intratumoral injection of R848 and poly(I:C) synergistically promoted antitumor immune responses by reprogramming macrophage polarization and activating DCs in lung cancer
Clinical & Experimental Immunology·2025· 7 cited
Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy
International Immunopharmacology·2024· 3 cited
The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence
Oncology Reports·2024· 6 citedOpen Access
Enhancing the revelation of key genes and interaction networks in non‐small cell lung cancer with major depressive disorder: A bioinformatics analysis
Health Science Reports·2024· 2 citedOpen Access
Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer
International Journal of Nanomedicine·2024· 22 citedOpen Access
Combinational delivery of TLR4 and TLR7/8 agonist enhanced the therapeutic efficacy of immune checkpoint inhibitors to colon tumor
Molecular and Cellular Biochemistry·2024· 2 cited
LEVI: Generalizable Fine-tuning via Layer-wise Ensemble of Different Views
arXiv (Cornell University)·2024Open Access
Ansofaxine Suppressed Nsclc Progression by Increasing Sensitization to Combination Immunotherapy
SSRN Electronic Journal·2024Open Access
Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model
Frontiers in Pharmacology·2023· 11 citedOpen Access
Combined use of TLR4 and TLR7/8 agonists to improve the efficacy of immune checkpoint inhibitors in “hot” tumor treatment and the establishment of long-term immune protection
Research Square (Research Square)·2023Open Access
Hiformer: Heterogeneous Feature Interactions Learning with Transformers for Recommender Systems
arXiv (Cornell University)·2023Open Access
Talking Models: Distill Pre-trained Knowledge to Downstream Models via Interactive Communication
arXiv (Cornell University)·2023Open Access
Psychological distress influences lung cancer: Advances and perspectives on the immune system and immunotherapy
International Immunopharmacology·2023· 23 cited
Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer
Biochemical and Biophysical Research Communications·2023· 9 cited
Induction of Trained Immunity Protects Neonatal Mice Against Microbial Sepsis by Boosting Both the Inflammatory Response and Antimicrobial Activity
Journal of Inflammation Research·2022· 20 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Jiawei Han(12), Linzhao Li(7), Yingjie Nie(7), Liyuan Liu(6), Qianyu Jing(6), Lan Zhu(6), Qi Zhu(5), Jin Ma(5), Huiting Zhou(5), Haohua Yuan(5), Shuanghui Chen(5), Hang Lv(5), Quan Wan(5), Xiang Ren(4), Yang Sun(4), Chenmei Mao(4), Sheng‐Ming Dai(4), Yi Zhang(4), Zhenjiang Bai(4), Chenglv Wang(4)